Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Celcuity Inc.

CELCNASDAQ
Healthcare
Biotechnology
$106.78
$0.00(0.00%)
U.S. Market is Open • 15:53

Celcuity Inc. Fundamental Analysis

Celcuity Inc. (CELC) shows weak financial fundamentals with a PE ratio of -28.72, profit margin of 0.00%, and ROE of -1.79%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

Current Ratio12.26

Areas of Concern

ROE-1.79%
Operating Margin0.00%
PEG Ratio4.50
We analyze CELC's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -173.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-173.9/100

We analyze CELC's fundamental strength across five key dimensions:

Efficiency Score

Weak

CELC struggles to generate sufficient returns from assets.

ROA > 10%
-34.19%

Valuation Score

Moderate

CELC shows balanced valuation metrics.

PE < 25
-28.72
PEG Ratio < 2
4.50

Growth Score

Weak

CELC faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-5.20%

Financial Health Score

Moderate

CELC shows balanced financial health with some risks.

Debt/Equity < 1
2.74
Current Ratio > 1
12.26

Profitability Score

Weak

CELC struggles to sustain strong margins.

ROE > 15%
-179.00%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is CELC Expensive or Cheap?

P/E Ratio

CELC trades at -28.72 times earnings. This suggests potential undervaluation.

-28.72

PEG Ratio

When adjusting for growth, CELC's PEG of 4.50 indicates potential overvaluation.

4.50

Price to Book

The market values Celcuity Inc. at 39.95 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

39.95

EV/EBITDA

Enterprise value stands at -33.81 times EBITDA. This is generally considered low.

-33.81

How Well Does CELC Make Money?

Net Profit Margin

For every $100 in sales, Celcuity Inc. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $-1.79 in profit for every $100 of shareholder equity.

-1.79%

ROA

Celcuity Inc. generates $-34.19 in profit for every $100 in assets, demonstrating efficient asset deployment.

-34.19%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-3.24 in free cash annually.

$-3.24

FCF Yield

CELC converts -2.98% of its market value into free cash.

-2.98%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-28.72

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

4.50

vs 25 benchmark

P/B Ratio

Price to book value ratio

39.95

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

2.74

vs 25 benchmark

Current Ratio

Current assets to current liabilities

12.26

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.79

vs 25 benchmark

ROA

Return on assets percentage

-0.34

vs 25 benchmark

ROCE

Return on capital employed

-0.36

vs 25 benchmark

How CELC Stacks Against Its Sector Peers

MetricCELC ValueSector AveragePerformance
P/E Ratio-28.7229.43 Better (Cheaper)
ROE-179.00%800.00% Weak
Net Margin0.00%-20145.00% (disorted) Weak
Debt/Equity2.740.30 Weak (High Leverage)
Current Ratio12.264.64 Strong Liquidity
ROA-34.19%-17936.00% (disorted) Weak

CELC outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Celcuity Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-312.72%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-260.68%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ